Acme United (NYSE:ACU) Given New $70.00 Price Target at Freedom Broker

Acme United (NYSE:ACU) had its price target upped by equities research analysts at Freedom Broker from $58.00 to $70.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a “hold” rating on the stock. Freedom Broker‘s target price suggests a potential upside of 4.71% from the company’s previous close.

Acme United Price Performance

Shares of ACU stock traded up $1.07 during mid-day trading on Wednesday, hitting $66.85. 34,014 shares of the stock traded hands, compared to its average volume of 24,458. Acme United has a twelve month low of $35.50 and a twelve month high of $67.32. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.91 and a current ratio of 4.41. The company’s 50-day simple moving average is $62.50 and its 200-day simple moving average is $49.96. The firm has a market cap of $254.70 million, a price-to-earnings ratio of 13.67 and a beta of 0.40.

Insiders Place Their Bets

In other news, Director Brian Barker sold 3,821 shares of the firm’s stock in a transaction dated Thursday, August 13th. The shares were sold at an average price of $60.50, for a total transaction of $231,170.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Rex Lynn Davidson sold 3,684 shares of Acme United stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $56.48, for a total transaction of $208,072.32. Following the completion of the transaction, the director directly owned 6,228 shares in the company, valued at $351,757.44. This represents a 37.17% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 26,063 shares of company stock worth $1,526,133. 29.50% of the stock is owned by corporate insiders.

Institutional Trading of Acme United

Large investors have recently added to or reduced their stakes in the business. Simplicity Wealth LLC acquired a new stake in shares of Acme United during the 3rd quarter valued at $371,000. Integrated Wealth Concepts LLC acquired a new position in shares of Acme United in the 2nd quarter worth $28,000. Nantahala Capital Management LLC acquired a new position in shares of Acme United in the 2nd quarter worth $974,776. Empowered Funds LLC acquired a new position in shares of Acme United in the 2nd quarter worth $257,000. Finally, Manatuck Hill Partners LLC acquired a new stake in shares of Acme United during the second quarter worth $379,000. 62.10% of the stock is currently owned by institutional investors.

Key Stories Impacting Acme United

Here are the key news stories impacting Acme United this week:

• Positive Sentiment: Strong quarterly growth and earnings beat: Third-quarter net sales rose 18% year over year to $58.0 million, while comparable sales excluding the My Medic acquisition increased 10%. Earnings of $0.80 per share exceeded the $0.71 consensus estimate, supporting the positive market reaction. Acme United Reports Third Quarter 2026 Net Sales Increase of 18%
• Positive Sentiment: Cost savings ahead: Acme United plans to close its DMT/Marlborough facility, a move expected to generate more than $1 million in annual savings beginning in January 2027. The savings could provide additional support for margins and future profitability. Acme United outlines DMT plant closure and annual savings
• Positive Sentiment: Business momentum remains constructive: Nine-month sales increased 16% to $173.0 million, or 8% on a comparable basis excluding My Medic. Management commentary and investor coverage indicate that the underlying operating performance is expected to remain solid. Acme United three key takeaways for long-term investors
• Neutral Sentiment: Acquisition contributed to growth: The My Medic acquisition helped lift reported sales, while comparable growth was more moderate. Investors will likely focus on whether the company can sustain organic growth and integrate the acquired business. Acme United Q3 earnings ride tariff refund boost
• Negative Sentiment: Quality of the earnings beat is a concern: Coverage highlighted that a tariff refund boosted third-quarter results, raising questions about how much of the earnings upside is recurring. One analyst viewed the operating performance favorably but said the current valuation was not attractive enough to chase the stock. Acme United Q3 performance and valuation analysis

Acme United Company Profile

Acme United Corporation is a manufacturer and supplier of first aid and medical products, cutting instruments, measuring tools and school and office supplies. The company serves the consumer, industrial, medical, school and office markets through a portfolio of branded and private-label products.

Its product offerings include workplace first aid cabinets and kits, medical and emergency supplies, scissors, shears, knives, sharpeners, rulers and other measuring instruments. Acme United markets products under brands such as PhysiciansCare, First Aid Only, Pac-Kit, Westcott and Clauss.

Founded in 1867, Acme United is headquartered in Fairfield, Connecticut, and serves customers in the United States, Canada and Europe.